MedPath

Lyrica

Brand Name: Lyrica

Generic Name: Pregabalin

Active
Registration Number

DR-XY32505

Dosage Form

Capsule

Issuance Date

August 22, 2022

Expiry Date

December 11, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25mg
PackagingAlu/PVC clear blister x 14's Box of 56's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Anti-epileptic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PregabalinActive
Monograph: Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform